Skip to content

인엑소플랫

  • About Us
    • Leadership
  • Our Science
    • Novel Cancer Therapy
    • Process
    • Development Strategy
  • Pipeline
    • Pipeline
    • IEP01
  • Newsroom
    • News
    • Story
    • FAQ
  • CDRO Service
    • About CDRO
    • BA Request for Proposal
    • PA Request for Proposal
  • 한국어
  • About Us
    • Leadership
  • Our Science
    • Novel Cancer Therapy
    • Process
    • Development Strategy
  • Pipeline
    • Pipeline
    • IEP01
  • Newsroom
    • News
    • Story
    • FAQ
  • CDRO Service
    • About CDRO
    • BA Request for Proposal
    • PA Request for Proposal
  • About Us
    • Leadership
  • Our Science
    • Novel Cancer Therapy
    • Process
    • Development Strategy
  • Pipeline
    • Pipeline
    • IEP01
  • Newsroom
    • News
    • Story
    • FAQ
  • CDRO Service
    • About CDRO
    • BA Request for Proposal
    • PA Request for Proposal
  • About Us
    • Leadership
  • Our Science
    • Novel Cancer Therapy
    • Process
    • Development Strategy
  • Pipeline
    • Pipeline
    • IEP01
  • Newsroom
    • News
    • Story
    • FAQ
  • CDRO Service
    • About CDRO
    • BA Request for Proposal
    • PA Request for Proposal

Story

  • [IEP X INSIGHT] Translocation of Extracellular vesicles across the blood-brain barrier

    Mechanism of EV transport across the BBB & application possibility as drug delivery system

  • [Process development] Quantification and characterization of Extracellular vesicles (EV)

    Analysis technologies for quantification and characterization of EVs

  • [IEP X INSIGHT] Therapeutic approaches of Extracellular vesicles (EV)

    Therapeutic / Diagnostic utility of exosomes

  • [IEP X INSIGHT] Exploring Extracellular vesicles (EVs)

    Breif review of extracellular vesicles and exosomes

  • [Process development] Various Chromatography Techniques and Basic Conditions

    Several chromatography techniques and basic methods of those techniques

  • [IEP X INSIGHT] Macrophage-targeted cancer therapies Part 3.

    Types of Immune Checkpoints for Modulating Macrophage Function and the Development of Macrophage-Based Cell Therapies

  • [IEP X INSIGHT] Macrophage-targeted cancer therapies Part 2.

    Strategies for Reprogramming or Activating Macrophages

  • [IEP X INSIGHT] Macrophage-targeted cancer therapies Part 1.

    About tumour-associated macrophages(TAMs)

  • [Process development] Mass spectrometry Part 3.

    About tandem mass spectrometry(MS/MS)

1 2 Next »
인엑소플랫 INEXOPLAT, Inc.

Headquarters 558, Handong-ro, Heunghae-eup, Buk-gu, Pohang-si, Gyeongsangbuk-do, 37554, South Korea (Office 403, Handong University Startup Incubation Center)
Reaserch institute 32, Songdo Science-ro, Yeonsu-gu, Incheon, 21995, South Korea (Room 2704, Building M, Songdo Techno Park IT Center)
Tel (+82) 32-215-2228  Fax (+82) 32-215-2229

COPYRIGHT © INEXOPLAT, Inc. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
  • Contact Us